Phio Pharmaceuticals Corp.
PHIO
|
News
|
$0.672
-4.0%
-4.17%
91K
|
Health Technology
(0.0% 1d) (-7.9% 1m) (-79.1% 1y) (0.0% 2d) (-15.7% 3d) (9.4% 7d) (-91.1% volume)
Earnings Calendar: 2022-11-09
Market Cap: $ 3,085,622
http://www.phiopharma.com
Sec Filling | Patents | 11 employees
(US) Phio Pharmaceuticals Corp. is a biotechnology company, which engages in the development of immuno-oncology therapeutics that addresses unmet medical needs. Its clinical product candidate includes RXI-109, an RNAi compound developed for the reduction of dermal scarring in planned surgeries. The company was founded on September 8, 2011 and is headquartered in Marlborough, MA.
dermatitis
add to watch list Paper trade email alert is off
Press-releases
Intratumoral Injection of Phio’s PH-762 significantly inhibits tumor growth in murine tumor models and may generate memory-specific T cells
Published: 2024-04-22 (Crawled : 17:00) - globenewswire.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: -1.56%
H: 66.67%
C: 31.75%
ph-762 tumor injection growth
Phio Pharmaceuticals Announces Upcoming Presentations at the 81st Annual Meeting of the Society for Investigative Dermatology (SID)
Published: 2024-04-16 (Crawled : 12:00) - phiopharma.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: -0.15%
H: 1.69%
C: 0.8%
pharmaceuticals for meeting
Phio Pharmaceuticals Announces Upcoming Presentation at the 27th Annual Meeting of the American Society of Cell and Gene Therapy (ASCGT)
Published: 2024-04-11 (Crawled : 12:00) - phiopharma.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: 3.8%
H: 1.15%
C: -1.19%
presentation cell pharmaceuticals meeting therapy
National Spotlight Features Phio’s Innovative RNAi Technology Platform
Published: 2024-04-03 (Crawled : 12:00) - phiopharma.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: 1.49%
H: 5.85%
C: 2.93%
technology platform
Phio Pharmaceuticals Reports 2023 Year End Financial Results and Provides Business Update
Published: 2024-04-02 (Crawled : 13:00) - phiopharma.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: -3.35%
H: 7.68%
C: 3.08%
business year update pharmaceuticals financial results
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
Published: 2024-03-21 (Crawled : 12:00) - phiopharma.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: -4.67%
H: 0.43%
C: -17.65%
cell pharmaceuticals therapy
Phio Pharmaceuticals Presenting Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies—Poster will be unveiled this week at the Immunotherapy Conference in Munich
Published: 2024-03-21 (Crawled : 12:30) - biospace.com/
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: -4.67%
H: 0.43%
C: -17.65%
conference cell pharmaceuticals immunotherapy week therapy
Phio Pharmaceuticals Announces Addition of Clinical Trial Sites at Banner MD Anderson Cancer Center, The George Washington University, and Integrity Research
Published: 2024-03-13 (Crawled : 18:00) - globenewswire.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: 1.96%
H: 0.0%
C: -9.48%
cancer pharmaceuticals research trial
Phio Pharmaceuticals Announces Patent Granted by USPTO, Strengthening the Company’s Intellectual Property Position in Treating Aging Skin and Skin Disorders
Published: 2024-03-06 (Crawled : 15:30) - globenewswire.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: 5.81%
H: 26.37%
C: 0.77%
patent granted disorders pharmaceuticals skin
Phio Pharmaceuticals Announces Data Showing INTASYL May Result in More Effective Cell Therapy for Hematological Malignancies
Published: 2024-01-31 (Crawled : 13:00) - globenewswire.com
PHIO | News | $0.672 -4.0% -4.17% 91K
|
Health Technology
|
| O: 2.25%
H: 15.0%
C: -1.0%
cell pharmaceuticals therapy
Last 15 days Sec forms
| File Id | Form | Published Date | Transaction Date | Direction | Code | Amount Transacted | Owned Amount |
| 0001683168-24-001134 | 4 | 2024-02-23 | 2024-02-20 | Sell | F | 1804 | 16490 |
Your Today's Watch List
Sign in to create a watchlistGainers vs Losers
| 62% | 38% |
Top 10 Gainers
CSSE 4 | $0.4323 183.85% 64.77% 220M
|
Consumer Services
BOF | $1.99 70.09% 41.21% 110M
|
ILAG | $0.51 6.03% 40.62% 1.7M
|
LICN | $0.941 68.04% 40.49% 15M
|
AMST | $3.31 65.5% 39.58% 70M
|
Technology Services
MTC | $3.615 61.38% 38.04% 9.3M
|
Technology Services
WIMI | $1.15 58.53% 36.92% 19M
|
Technology Services
AIH | $0.45 12.5% 30.92% 320K
|
Health Services
MULN | News | $3.78 38.46% 27.78% 13M
|
Information
RILY | $29.86 37.48% 27.26% 12M
|
Finance
Last 48 Hours Insiders Buying
RKT P 347 | $12.55 -0.63% 0.48% 1.7M
|
Finance
|
22:30
NWFL | News | $24.6 2.03% 1.99% 9.9K
|
Finance
|
22:00
TGEN P 16000 | $0.685 39.71% 6.6K
|
Utilities
|
20:01
WABC | $47.86 0.21% 0.21% 140K
|
Finance
|
19:30
MNSB P 310 | $15.88 -2.93% -3.02% 46K
|
Finance
|
15:30
TPL P 3 | $589.01 0.2% -0.04% 53K
|
Miscellaneous
|
15:01
ISBA P 966 | $18.0001 1.63% 3.1K
|
Finance and Insurance
|
15:01
MEGI | $12.04 0.5% 0.0% 150K
|
|
00:30
CTRN P 29000 | $22.11 -0.54% -0.54% 65K
|
Retail Trade
|
22:00
CONN | $3.78 2.16% 2.12% 36K
|
Retail Trade
|
21:30
CMTV P 700 | $16.59 17.43% 1K
|
Finance and Insurance
|
18:30
FNB | $13.67 0.29% 0.0% 2.2M
|
Finance
|
17:30
RMCF | $3.54 0.28% 7.1K
|
Consumer Non-Durables
|
20:10